118 related articles for article (PubMed ID: 16409423)
1. Long-term management of patients with symptoms of gastro-oesophageal reflux disease -- a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting.
Hansen AN; Bergheim R; Fagertun H; Lund H; Wiklund I; Moum B
Int J Clin Pract; 2006 Jan; 60(1):15-22. PubMed ID: 16409423
[TBL] [Abstract][Full Text] [Related]
2. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.
Norman Hansen A; Bergheim R; Fagertun H; Lund H; Moum B
Int J Clin Pract; 2005 Jun; 59(6):665-71. PubMed ID: 15924594
[TBL] [Abstract][Full Text] [Related]
3. Six-month management of patients following treatment for gastroesophageal reflux disease symptoms -- a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting.
Hansen AN; Wahlqvist P; Jørgensen E; Bergheim R; Fagertun H; Lund H; Moum B
Int J Clin Pract; 2005 Jun; 59(6):655-64. PubMed ID: 15924593
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
[TBL] [Abstract][Full Text] [Related]
5. Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study.
Tsai HH; Chapman R; Shepherd A; McKeith D; Anderson M; Vearer D; Duggan S; Rosen JP;
Aliment Pharmacol Ther; 2004 Sep; 20(6):657-65. PubMed ID: 15352914
[TBL] [Abstract][Full Text] [Related]
6. A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.
Johnson DA; Stacy T; Ryan M; Wootton T; Willis J; Hornbuckle K; Brooks W; Doviak M
Aliment Pharmacol Ther; 2005 Jul; 22(2):129-34. PubMed ID: 16011671
[TBL] [Abstract][Full Text] [Related]
7. Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis.
Sjöstedt S; Befrits R; Sylvan A; Harthon C; Jörgensen L; Carling L; Modin S; Stubberöd A; Toth E; Lind T
Aliment Pharmacol Ther; 2005 Aug; 22(3):183-91. PubMed ID: 16091055
[TBL] [Abstract][Full Text] [Related]
8. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
9. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
[TBL] [Abstract][Full Text] [Related]
10. Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastro-oesophageal reflux symptoms in primary care.
Meineche-Schmidt V; Juhl HH; Østergaard JE; Luckow A; Hvenegaard A
Aliment Pharmacol Ther; 2004 Apr; 19(8):907-15. PubMed ID: 15080852
[TBL] [Abstract][Full Text] [Related]
11. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
Johnsson F; Hatlebakk JG; Klintenberg AC; Román J; Toth E; Stubberöd A; Falk A; Edin R
Scand J Gastroenterol; 2003 Apr; 38(4):354-9. PubMed ID: 12739706
[TBL] [Abstract][Full Text] [Related]
12. Review article: is stringent control of gastric pH useful and practical in GERD?
Kahrilas PJ
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():89-94; discussion 95-6. PubMed ID: 15456470
[TBL] [Abstract][Full Text] [Related]
13. Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial.
Goldstein JL; Johanson JF; Suchower LJ; Brown KA
Am J Gastroenterol; 2005 Dec; 100(12):2650-7. PubMed ID: 16393215
[TBL] [Abstract][Full Text] [Related]
14. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.
Kiljander TO; Junghard O; Beckman O; Lind T
Am J Respir Crit Care Med; 2010 May; 181(10):1042-8. PubMed ID: 20110554
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
17. Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study.
Katz PO; Castell DO; Chen Y; Andersson T; Sostek MB
Aliment Pharmacol Ther; 2004 Aug; 20(4):399-406. PubMed ID: 15298633
[TBL] [Abstract][Full Text] [Related]
18. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease.
Metz DC; Miner PB; Heuman DM; Chen Y; Sostek M
Aliment Pharmacol Ther; 2005 Nov; 22(9):813-21. PubMed ID: 16225490
[TBL] [Abstract][Full Text] [Related]
20. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.
van Zanten SV; Armstrong D; Chiba N; Flook N; White RJ; Chakraborty B; Gasco A
Am J Gastroenterol; 2006 Sep; 101(9):2096-106. PubMed ID: 16817845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
